CLINICAL_TRIALS
trial_result
· 2019-12-23
Clinical Trial Update: A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers [Phase 1]
Summary
Phase 1 trial assessing M207 with intranasal zolmitriptan in healthy volunteers has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zosano Pharma Corporation | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2019-12-23